Clinical Trials on Hormone-resistant Prostate Cancer in Canada
Total 1119 results
-
Sunnybrook Health Sciences CentreProstate Cure FoundationActive, not recruiting
-
Sunnybrook Health Sciences CentreActive, not recruiting
-
Sunnybrook Health Sciences CentreActive, not recruitingProstate CancerCanada
-
University of AlbertaCompleted
-
Sunnybrook Health Sciences CentreActive, not recruiting
-
Centre hospitalier de l'Université de Montréal...Completed
-
Sunnybrook Health Sciences CentreCanadian Association of Radiation OncologyCompleted
-
Grand River HospitalSt. Joseph's Healthcare HamiltonUnknownProstate CancerCanada
-
University Health Network, TorontoCompleted
-
Lawson Health Research InstituteTerminated
-
University Health Network, TorontoCanadian Cancer Society (CCS)Completed
-
University Health Network, TorontoCompleted
-
Centre for Global eHealth InnovationUniversity Health Network, Toronto; Trillium Health PartnersUnknown
-
Lawson Health Research InstituteCompleted
-
University Health Network, TorontoProstate Cancer CanadaCompleted
-
AHS Cancer Control AlbertaCompleted
-
AHS Cancer Control AlbertaCross Cancer InstituteCompletedProstate CancerCanada
-
University Health Network, TorontoCompletedProstate CancerCanada
-
Sunnybrook Health Sciences CentrePhilips HealthcareCompletedProstate CancerCanada
-
University Health Network, TorontoCompleted
-
Dr. Laurence KlotzUnknown
-
Lawson Health Research InstituteUniversity of Western Ontario, Canada; London Regional Cancer Program, CanadaTerminatedProstate CancerCanada
-
Sunnybrook Health Sciences CentreToronto Sunnybrook Regional Cancer CentreCompleted
-
Alberta Health servicesTerminated
-
Canadian Urology Research ConsortiumAstraZenecaCompleted
-
University of ManitobaManitoba Medical Service FoundationCompleted
-
University of ManitobaHealth Sciences Centre Foundation, ManitobaCompleted
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
BayerCompletedMetastatic Castration-sensitive Prostate CancerCanada
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Hormone Sensitive Prostate CancerCanada, United States, France, Spain, Australia, Sweden, Taiwan, Finland, Korea, Republic of, Netherlands, United Kingdom, Denmark, Brazil, Slovakia, Austria, Italy, Poland
-
McGill University Health Centre/Research Institute...SanofiRecruitingProstate CancerCanada
-
British Columbia Cancer AgencyCompleted
-
SonaCare MedicalUnknown
-
British Columbia Cancer AgencyBiocompatibles UK LtdCompleted
-
Nova Scotia Health AuthorityDalhousie University; Queen Elizabeth II Health Sciences CentreCompleted
-
British Columbia Cancer AgencyCompleted
-
British Columbia Cancer AgencyTerminated
-
British Columbia Cancer AgencyUnknown
-
British Columbia Cancer AgencyUnknown
-
Canadian Urology Research ConsortiumOICR; EigenUnknown
-
University of British ColumbiaUnknownProstate CancerCanada
-
Sunnybrook Health Sciences CentreActive, not recruitingProstate Cancer RecurrentCanada
-
Canadian Urology Research ConsortiumFerring PharmaceuticalsTerminated
-
British Columbia Cancer AgencyUniversity of British Columbia; Vancouver Prostate Centre; BC Cancer FoundationRecruitingLocalized Prostate CarcinomaCanada
-
Nova Scotia Health AuthorityRecruiting
-
British Columbia Cancer AgencyRecruitingProstate CancerCanada
-
CR-CSSS Champlain-Charles-Le MoyneSuspendedProstate CancerCanada
-
British Columbia Cancer AgencyUnknown